Rare diseases
Investigational molecules
Locations
Back to Germany767 clinical trials in Leipzig, Germany across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyStudy on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
GermanyStudy on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy
GermanyStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
GermanyStudy on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet
GermanyStudy on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus
GermanyStudy on the Effects of MORF-057 for Adults with Moderate to Severe Crohn's Disease
GermanyStudy of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer
GermanyStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
GermanyStudy on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis
GermanyStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
GermanyStudy on Efruxifermin for Patients with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH)
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on respiratory infections and preventive vaccines, including studies for RSV and human metapneumovirus in elderly populations, as well as research on uncontrolled asthma treatments.
Novel therapeutic approaches are being evaluated to protect vulnerable populations against respiratory infections.
Innovative studies targeting various cancer types, with emphasis on breast cancer, lung cancer, and gastric cancer treatments using targeted therapies and immunotherapy approaches.
Focus on personalized treatment approaches and novel drug combinations to improve patient outcomes.
Research centered on preventing and treating various infections, including studies of meningococcal vaccines in different age groups and cytomegalovirus prevention strategies.
Comprehensive vaccine trials aimed at protecting diverse population groups against serious infections.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
